Skip to content

A Study on the Effects of Using a Vein Visualization Device on Pain and Success Rate of Intravenous Injections in Hospitalized Older Patients

Effects of Near-Infrared Vein Visualization Device-Assisted Peripheral Intravenous Cannulation on Pain and Success Rate in Older Inpatients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011663
Enrollment
90
Registered
2026-02-26
Start date
2026-02-12
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Near-Infrared (NIR) Vein Visualization Device) : This study is conducted by recruiting hospitalized patients who have had intravenous (IV) insertion experience within the past 6 months and expr

Sponsors

Eulji University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals aged 65 years or older who receive an explanation of the study, provide informed consent, and are able to communicate effectively. 2. Patients scheduled for intravenous (IV) insertion who have had previous IV insertion experience within the past 6 months. 3. Patients scheduled to receive their first intravenous insertion after hospital admission.

Exclusion criteria

Exclusion criteria: 1. Individuals who have received or are scheduled to receive pharmacological or non-pharmacological interventions for the purpose of reducing pain or anxiety related to intravenous (IV) insertion within 1 hour prior to the procedure. - Pharmacological interventions: Sedatives, lidocaine, EMLA cream, or other local anesthetics administered to alleviate IV insertion-related pain or anxiety. - Non-pharmacological interventions: Cold or warm compresses, massage, music therapy, aromatherapy, relaxation therapy, or similar interventions. 2. Individuals with psychological or cognitive impairments, or diagnosed psychiatric disorders that may interfere with judgment or communication. 3. Individuals currently undergoing or with a history of chemotherapy or hemodialysis. 4. Individuals with skin conditions that may increase the risk of injury or infection at the insertion site, including active dermatologic diseases, infectious lesions, burns, or severe peripheral edema.

Design outcomes

Primary

MeasureTime frame
Insertion time;Overall success rate

Secondary

MeasureTime frame
Anxiety ;Patient satisfaction

Countries

Korea, Republic of

Contacts

Public ContactBae kyunghwa

Eulji University Hospital

sori1004@eulji.ac.kr+82-42-611-3093

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 14, 2026